Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves MedImmune four-strain flu vaccine
FluMist Quadrivalent contains four strains (two type A strains and two type B lineages) to help provide broad protection against circulating influenza A and B. The quadrivalent vaccine
FluMist Quadrivalent contains four strains (two type A strains and two type B lineages) to help provide broad protection against circulating influenza A and B. The quadrivalent vaccine
As per the agreement, Abbott will make an initial upfront payment of $150m for rights related to the global collaboration. Upon successful completion of the RA Phase II
Lexapro tablets are used for acute and maintenance treatment of major depressive disorder (MDD) and acute treatment of generalized anxiety disorder (GAD). Mylan will sell the product exclusively
Avonex Pen (Avonex 30mcg/0.5mL solution for injection) is the first single-use, once-a-week, fully integrated intramuscular (IM)autoinjector, designed to be easier to use than currently available Avonex prefilled syringe.
The University of California San Francisco has received Investigational Review Board (IRB) approval. The single-arm, open-label and multi-center study will enroll up to 25 patients with stage III
ET-101 is a novel therapeutic antibody, currently under investigation for the inhibition of the growth of cancer stem cells. Under the deal, Lonza will produce phase 1 clinical
The company is expected to initiate a Phase I trial with mibefradil in normal healthy volunteers on 2 March 2012. The company will also initiate Phase Ib trial
In January 2011, Dompé has acquired 49% stake in Anabasis and also patent rights for the use of NGF to treat neurotrophic keratitis (NK). Dompé will become the
KDIL is a contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma. Akorn is a pharmaceutical company engaged in the development, manufacture
NanoSonic’s Trappsol Cyclo is FDA and EMEA designated orphan drug for the treatment of Niemann Pick Type-C disease, also known as Childhood Alzheimer’s. Trappsol Cyclo is currently being